Table 1.

Sample characteristics by age group

Characteristics	Age category										pa
	25–44 (n = 132)		45–54 (n = 209)		55–64 (n = 167)		65–74 (n = 102)		75+ (n = 43)
	No.	Col %	No.	Col %	No.	Col %	No.	Col %	No.	Col %
Depression category											<0.001
Normal (BDI score 0–9)	56	42.4	118	56.5	117	70.1	81	79.4	35	81.4
Mild (BDI score 10–18)	59	44.7	74	35.4	37	22.2	17	16.7	7	16.3
Moderate (BDI score 19–29)	15	11.4	15	7.2	11	6.6	2	2.0	1	2.3
Severe (BDI score 30+)	2	1.5	2	1.0	2	1.2	2	2.0	0	0.0
Sociodemographics/patient characteristics
Non-Hispanic white race	116	87.9	189	90.4	143	85.6	95	93.1	42	97.7	0.100
Married/partnered	92	69.7	165	79.0	118	70.7	71	69.6	22	51.2	0.006
Children under age 18 in home	82	62.1	82	39.2	7	4.2	0	0.0	0	0.0	<0.001
Household income in thousands											<0.0001
<20	15	11.6	11	5.4	12	7.3	7	7.5	1	2.4
20–49.9	17	13.2	15	7.4	29	17.7	29	30.9	21	50.0
50–100	40	31.0	62	30.4	47	28.7	38	40.4	11	26.2
>100	57	44.2	116	56.9	76	46.3	20	21.3	9	21.4
Employed full or part-time	58	43.9	122	58.4	74	44.3	14	13.7	4	9.3	<0.001
Education											<0.001
≤HS graduate	13	9.8	18	8.6	22	13.2	22	21.6	7	16.3
Some college	20	15.2	53	25.4	41	24.6	31	30.4	17	39.5
College graduate	46	34.8	44	21.1	32	19.2	19	18.6	8	18.6
>College graduate	53	40.2	94	45.0	72	43.1	30	29.4	11	25.6
Comorbidities											<0.001
None	87	66.4	99	47.8	43	25.9	12	11.9	2	4.7
1–2	41	31.3	91	44.0	87	52.4	53	52.5	20	46.5
≥3	3	2.3	17	8.2	36	21.7	36	35.6	21	48.8
Cancer-related variables
Stage of disease											<0.001
I	45	34.1	108	51.7	91	54.5	62	60.8	32	74.4
II	73	55.3	84	40.2	63	37.7	34	33.3	8	18.6
III	14	10.6	17	8.1	13	7.8	6	5.9	3	7.0
Type of surgery											<0.001
No surgeryb	9	6.8	9	4.3	7	4.2	2	2.0	0	0.0
Mastectomy	56	42.4	72	34.4	35	21.0	26	25.5	8	18.6
Lumpectomy	67	50.8	128	61.2	125	74.9	74	72.5	35	81.4
Radiation											<0.001
No radiationb	123	93.2	166	79.4	118	70.7	58	56.9	24	55.8
Radiation	9	6.8	43	20.6	49	29.3	44	43.1	19	44.2
Chemotherapy											<0.001
No chemotherapyb	29	22.0	71	34.0	68	40.7	58	56.9	38	88.4
Chemotherapy with doxorubicin	90	68.2	107	51.2	68	40.7	24	23.5	2	4.7
Chemotherapy no doxorubicin	13	9.8	31	14.8	31	18.6	20	19.6	3	7.0
Symptoms
Vasomotor symptoms											<0.001
None	59	44.7	67	32.1	63	37.7	56	54.9	34	79.1
Mild	29	22.0	69	33.0	54	32.3	26	25.5	5	11.6
Moderate	31	23.5	46	22.0	33	19.8	18	17.6	3	7.0
Severe	13	9.8	27	12.9	17	10.2	2	2.0	1	2.3
Bodily pain											0.002
None	15	11.4	35	16.7	36	21.6	24	23.5	8	18.6
Very mild	20	15.3	58	27.8	50	29.9	33	32.4	10	23.3
Mild	25	19.1	48	23.0	27	16.2	16	15.7	11	25.6
Moderate	51	38.9	53	25.4	44	26.3	21	20.6	11	25.6
Severe	19	14.5	11	5.3	10	6.0	8	7.8	3	7.0
Very severe	1	0.8	4	1.9	0	0.0	0	0.0	0	0.0

Characteristics	Means and standard deviations					pa
	Age category
	25–44 (n = 132)	45–54 (n = 209)	55–64 (n = 167)	65–74 (n = 102)	75+ (n = 43)
Mean time since diagnosis (months) Spirituality (mean)	4.2 (1.4)	4.6 (1.3)	4.6 (1.3)	4.9 (1.1)	4.4 (1.1)	0.001
Role of faith	8.8 (5.0)	9.6 (5.1)	10.3 (4.9)	11.0 (4.3)	8.6 (4.5)	0.003
Meaning	12.7 (2.9)	13.2 (2.8)	13.5 (2.9)	13.4 (2.9)	13.3 (2.9)	0.133
Peace	9.3 (3.6)	10.0 (4.1)	11.4 (3.9)	11.7 (3.4)	10.5 (3.2)	<0.001
Illness intrusiveness (mean)	54.6 (20.0)	47.1 (20.9)	40.4 (19.5)	31.9 (17.3)	25.7 (13.3)	<0.001
Active coping (mean)	2.7 (2.7)	2.7 (2.7)	2.6 (2.6)	2.3 (2.3)	2.0 (2.0)	<0.001
Passive coping (mean)	1.4 (0.4)	1.3 (0.4)	1.3 (0.4)	1.3 (0.4)	1.3 (0.4)	0.090
Perceived attractiveness (mean)	9.4 (2.3)	9.8 (2.5)	10.9 (2.2)	11.0 (2.0)	10.9 (1.8)	<0.001
Social support (mean)	4.3 (0.7)	4.4 (0.7)	4.4 (0.6)	4.2 (0.8)	4.1 (0.8)	0.035
Optimism (mean)	25.3 (5.5)	25.6 (5.8)	26.7 (5.8)	26.6 (5.4)	25.7 (5.1)	0.17

^ap value for differences by age group

^bNo surgery, radiation, or chemotherapy before baseline survey